Showing results (2331-2340 of 3,717) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|February 20, 2010
A natural compound, methyl angolensate, induces mitochondrial pathway of apoptosis in Daudi cellsKishore K Chiruvella, Sathees C RaghavanInvestigational New Drugs|July 30, 2018
Combination treatment of cancer cells with pan-Akt and pan-mTOR inhibitors: effects on cell cycle distribution, p-Akt expression level and radiolabelled-choline incorporationSu Myat Phyu, Tim A D SmithInvestigational New Drugs|August 15, 2018
Phase 1 dose-escalation study of momelotinib, a Janus kinase 1/2 inhibitor, combined with gemcitabine and nab-paclitaxel in patients with previously untreated metastatic pancreatic ductal adenocarcinomaKimmie Ng, Andrew Hendifar, Alexander Starodub, et al.Investigational New Drugs|July 19, 2018
Design, synthesis and antiproliferative evaluation of novel sulfanilamide-1,2,3-triazole derivatives as tubulin polymerization inhibitorsShewei Guo, Yingwei Zhen, Mengguo Guo, et al.Investigational New Drugs|July 19, 2018
Hand-foot-skin reaction of grade ≥ 2 within sixty days as the optimal clinical marker best help predict survival in sorafenib therapy for HCCEnxin Wang, Dongdong Xia, Wei Bai, et al.Investigational New Drugs|August 4, 2018
Characterization and phase I study of CLR457, an orally bioavailable pan-class I PI3-kinase inhibitorJames J Harding, Todd M Bauer, Daniel S W Tan, et al.Investigational New Drugs|January 1, 1985
Evaluation of a new drug 7-N-(p-hydroxyphenyl)-mitomycin C [KW 2083] against carcinoma of the lung by the human tumor clonogenic assayF Kanzawa, Y Matsushima, A Hoshi, et al.Investigational New Drugs|June 2, 2017
Clinical parameters associated with anti-programmed death-1 (PD-1) inhibitors-induced tumor response in melanoma patientsValentine Heidelberger, François Goldwasser, Nora Kramkimel, et al.Investigational New Drugs|December 28, 2005
Phase I clinical trial of weekly docetaxel and exisulind, a novel inducer of apoptosisAgustin A Garcia, Syma Iqbal, David Quinn, et al.Investigational New Drugs|December 28, 2005
The combination of sulfinosine and 8-Cl-cAMP induces synergistic cell growth inhibition of the human neuroblastoma cell line in vitroDragana Janković, Milica Pesić, Jasna Marković, et al.Pageof 372